Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40-CD40 ligand interaction
暂无分享,去创建一个
[1] R. Noelle,et al. Cognate interactions between helper T cells and B cells. III. Contact-dependent, lymphokine-independent induction of B cell cycle entry by activated helper T cells. , 1989, Journal of immunology.
[2] I. Maclennan,et al. Marginal zones: the major B cell compartment of rat spleens , 1981, European journal of immunology.
[3] B. Hausmann,et al. B lymphocytes in vivo fail to prime naive T cells but can stimulate antigen-experienced T lymphocytes , 1993, The Journal of experimental medicine.
[4] L. Herzenberg,et al. Localization of murine Ig-1b and Ig-1a (IgG 2a) allotypic determinants detected with monoclonal antibodies. , 1979, Molecular immunology.
[5] P. Lipsky,et al. Analysis of the mechanisms of T cell-dependent polyclonal activation of human B cells. Induction of human B cell responses by fixed activated T cells. , 1991, Journal of immunology.
[6] R. Noelle,et al. Cognate interactions between helper T cells and B cells. V. Reconstitution of T helper cell function using purified plasma membranes from activated Th1 and Th2 T helper cells and lymphokines. , 1991, Journal of immunology.
[7] A. Aruffo,et al. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory , 1994, The Journal of experimental medicine.
[8] C. Maliszewski,et al. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion , 1992, The Journal of experimental medicine.
[9] J. Schröder,et al. Activation to IgG secretion by lipopolysaccharide requires several proliferation cycles. , 1979, Journal of immunology.
[10] E. C. Snow,et al. Cognate interactions between helper T cells and B cells. , 1990, Immunology today.
[11] D. Gray,et al. Virgin B cell recruitment and the lifespan of memory clones during antibody responses to 2,4‐dinitrophenyl‐hemocyanin , 1986, European journal of immunology.
[12] C. Smith,et al. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. , 1990, Science.
[13] P. Linton,et al. Primary antibody-forming cells and secondary B cells are generated from separate precursor cell subpopulations , 1989, Cell.
[14] H. Mitsuya,et al. Evidence for the failure of IgA specific T helper activity in a patient with immunodeficiency with hyper IgM. , 1979, Journal of clinical & laboratory immunology.
[15] G. Guy,et al. Synergistic interaction between interleukin 4 and anti‐Bp50 (CDw40) revealed in a novel B cell restimulation assay , 1987, European journal of immunology.
[16] A. Aruffo,et al. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions , 1993, The Journal of experimental medicine.
[17] H. Müller-Eberhard,et al. DEFICIENCY OF THE FIFTH COMPONENT OF COMPLEMENT IN MICE WITH AN INHERITED COMPLEMENT DEFECT , 1967, The Journal of experimental medicine.
[18] J. Bajorath,et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome , 1993, Cell.
[19] J. Banchereau,et al. Activation of human B lymphocytes through CD40 and interleukin 4 , 1989, European journal of immunology.
[20] P. Pereira,et al. T Cell‐Dependent B Cell Activation , 1984, Immunological reviews.
[21] R. Coffman,et al. Separation of events mediating B cell proliferation and Ig production by using T cell membranes and lymphokines. , 1990, Journal of immunology.
[22] Andrew H. Liu,et al. DEFECTIVE EXPRESSION OF T-CELL CD40 LIGAND CAUSES X-LINKED IMMUNODEFICIENCY WITH HYPER IgM , 1994, Pediatrics.
[23] H. Spits,et al. CD40 is functionally expressed on human thymic epithelial cells. , 1992, Journal of immunology.
[24] E. Clark,et al. Soluble forms of CD40 inhibit biologic responses of human B cells. , 1992, Journal of immunology.
[25] A. Fischer,et al. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM , 1993, Nature.
[26] M. Cooper,et al. The T cell dependence of B cell differentiation induced by pokeweed mitogen. , 1976, Journal of immunology.
[27] A. Aruffo,et al. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39 , 1993, The Journal of experimental medicine.
[28] I. Maclennan,et al. Germinal center cells express bcl‐2 protein after activation by signals which prevent their entry into apoptosis , 1991, European journal of immunology.
[29] I. Stamenkovic,et al. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[30] H. Stein,et al. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease , 1992, Cell.
[31] G. Kelsoe,et al. In situ studies of the primary immune response to (4-hydroxy-3- nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations , 1991, The Journal of experimental medicine.
[32] M. Cooper,et al. Hyper IgM immunodeficiency. A primary dysfunction of B lymphocyte isotype switching. , 1983, The Journal of clinical investigation.
[33] R. Geha,et al. Hyper immunoglobulin M immunodeficiency. (Dysgammaglobulinemia). Presence of immunoglobulin M-secreting plasmacytoid cells in peripheral blood and failure of immunoglobulin M-immunoglobulin G switch in B-cell differentiation. , 1979, The Journal of clinical investigation.
[34] David Gray,et al. Expansion, Selection and Mutation of Antigen‐Specific B Cells in Germinal Centers , 1992, Immunological reviews.
[35] Klaus Rajewsky,et al. Intraclonal generation of antibody mutants in germinal centres , 1991, Nature.
[36] K. Rajewsky,et al. Expansion and functional activity of Ly‐1+ B cells upon transfer of peritoneal cells into allotype‐congenic, newborn mice , 1987, European journal of immunology.
[37] I. Stamenkovic,et al. A B‐lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. , 1989, The EMBO journal.
[38] D. Gray,et al. Activated human T cells express a ligand for the human B cell‐associated antigen CD40 which participates in T cell‐dependent activation of B lymphocytes , 1992, European journal of immunology.
[39] H. Karasuyama,et al. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors , 1988, European journal of immunology.
[40] H. Ochs,et al. B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells , 1993, The Journal of experimental medicine.
[41] J. Banchereau,et al. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. , 1991, Science.
[42] R. Coffman,et al. Mechanism and regulation of immunoglobulin isotype switching. , 1993, Advances in immunology.
[43] Atsushi Hase,et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis , 1991, Cell.
[44] I. Stamenkovic,et al. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co‐stimulatory activity. , 1992, The EMBO journal.
[45] E. Clark,et al. Molecular and biological characterization of a murine ligand for CD40 , 1992, Nature.